Erysipelas

EBM Guidelines
Dec 18, 2023 • Latest change Mar 17, 2025
Alexander Salava

Table of contents

Extract

  • Erysipelas is diagnosed on the basis of clinical presentation and increased inflammatory markers.
  • Differential diagnostic alternatives include conditions such as suppurative and necrotising skin infections and infections associated with ischaemia or neuropathic ulcer in patients with diabetes.
  • Penicillin administered either orally or parenterally depending on the severity of the disease and the patient’s risk factors is the first-line treatment.
  • The duration of treatment depends on the response; antimicrobial treatment of 7–14 days is usually sufficient.
  • In recurrent erysipelas, predisposing factors should be treated and prophylactic treatment started, as necessary.

Read full article of Erysipelas

Linked evidence summaries

Search terms

A46, Blister, Cellulitis, Clindamycin, Dermatology, Edema, Erysipelas, Fever, Infectious diseases, Penicillin G, Penicillin G, Procaine, Penicillin V, Staphylococcus, Ulcer, antimicrobial therapy, benzathine penicillin, penicillin allergy